window.dataLayer = window.dataLayer || []; function gtag(){dataLayer.push(arguments);} gtag('js', new Date()); gtag('config', 'G-4PR1PSYQLJ'); Skip to content

Welcome to Discover Pharma! Today is : July 4, 2026

  • News
  • Featured News Archives
    • 12 Days of Christmas
    • Women in Pharma
  • About Us
Contact Us

Blood Brain Barrier

  • Advanced Therapies,Biotech & Pharma Business,Drug Discovery & Development

    Lonza acquires Nona blood-brain barrier technology for CNS therapies

    Lonza has acquired the rights to Nona Biosciences’ transferrin receptor [...]

    July 3, 2026
  • Biotech & Pharma Business,Central Nervous System,Drug Discovery & Development

    Deep Science Ventures and Medicines Discovery Catapult target blood-brain barrier challenge

    Deep Science Ventures and Medicines Discovery Catapult have launched a [...]

    June 6, 2026
  • Biotech & Pharma Business,Therapeutic Areas

    Chiesi and Key2Brain extend global partnership to advance blood-brain barrier-crossing therapies for ultra-rare diseases

    Chiesi Group has signed a worldwide license agreement with Swedish [...]

    May 5, 2026
  • Drug Delivery & Formulation

    Carthera hits major recruitment milestone in glioblastoma trial using BBB-opening ultrasound device

    Carthera has enrolled the first 100 participants in its Sonobird [...]

    April 24, 2025

Bringing you the latest industry news and insights every day

Registered Address: Discover Pharma Ltd, 1 Dartmouth Close, Brighton, BN2 4HZ, UK
Company Number: 16239596

  • About Us
  • Contact Us
  • Legal
    • Cookie Policy
    • Privacy Policy
    • Terms & Conditions
  • Author Guidelines
    • Pharmaceutical Author Guidelines
    • Press Release Advice
  • Advertise with Us
  • Media Kit Request

© 2026 Discover Pharma. All rights reserved • Developed by Hairy Goat Design

Page load link

Press “ESC” key to close

main menu
  • Home
  • News
  • About Us
  • Contact
recent posts
  • Lonza expands HPAPI capacity to support ADC manufacturing
    Categories: Advanced Therapies, Manufacturing & Supply Chain, Pharmaceuticals and therapeutics
  • Inaqovi combination wins EU approval for AML treatment
    Categories: Clinical & Regulatory, Pharmaceuticals and therapeutics, Therapeutic Areas
  • Grifols doses first patient in Phase 3 alpha-1 therapy trial
    Categories: Clinical & Regulatory, Pharmaceuticals and therapeutics, Research & Development, Therapeutic Areas
get connected
This website uses cookies and third party services. See our Cookie Policy and Privacy Policy pages for details. OK
Go to Top